Bold Science Reforms To Fuel Economic Growth
These reforms are about unlocking the full potential of science to deliver stronger economic growth and greater resilience for New Zealand.
Minister of Science, Innovation and Technology
The Government is moving swiftly to implement the most significant science reforms in three decades, with three new public research organisations to be formed by 1 July, Science, Innovation and Technology Minister Dr Shane Reti announced today.
'These reforms are about unlocking the full potential of science to deliver stronger economic growth and greater resilience for New Zealand. We're not wasting a moment,' says Dr Reti.
'Earlier this year, the Prime Minister unveiled a major overhaul of the science system, including the move from seven Crown Research Institutes to three new, future-focused entities. These new organisations will concentrate on key areas of national importance.'
The new institutes will be:
New Zealand Institute for Bioeconomy Science – advancing innovation in agriculture, aquaculture, forestry, biotechnology and manufacturing; protecting ecosystems from biosecurity threats and climate risks; and developing new bio-based technologies and products.
New Zealand Institute for Earth Science – supporting energy security and sustainability; developing land, marine and mineral resources; and improving resilience to natural hazards and climate-related risks.
New Zealand Institute for Public Health and Forensic Science – strengthening public health through disease detection and response; and supporting public safety through forensic science services.
'These institutes will ensure our world-class researchers are focused on delivering science that drives innovation, supports our industries, and improves the lives of everyday New Zealanders,' says Dr Reti.
'Critically, the new research organisations will have a strong commercial focus, with a mandate to translate science into real-world outcomes and commercial success.
'It's not enough to have great science — we need that science to power start-ups, lift productivity, and create jobs. This is about turning research into results for New Zealand's economy.'
To lead this transformation, Dr Reti today announced the appointment of Barry Harris as Chair of the Bioeconomy Science Institute, and David Smol as Chair of the Earth Science Institute.
'Both Mr Harris and Mr Smol bring outstanding leadership and deep sector experience. They are well placed to guide these new organisations as they take shape and begin delivering on our vision for a stronger, more productive science system,' says Dr Reti.
The Institute of Environmental Science and Research (ESR) will retain its current governance as it transitions to become the New Zealand Institute for Public Health and Forensic Sciences.
'These changes are about focus, outcomes, and value. We are investing in science that delivers for New Zealand — science that strengthens our economy, supports our environment, and builds resilience for the future,' Dr Reti says.
'I'm confident these new leaders will help us deliver a science system that is more connected, more commercially focused, and better aligned with the needs of our nation.'
Notes:
A Chair and directors have been appointed to govern the bioeconomy Crown Research Institute as well as a Chair and directors to govern the earth sciences Crown Research Institute.
Both entities will be formed on 1 July and formally established as public research organisations once new legislation is in place.
Bioeconomy board appointments:
Barry Harris – Chair for a three-year term
Kim Wallace – Deputy Chair for a two-year term
Candace Kinser – Director for a three-year term
Andrew Morrison – Director for a two-year term
Gray Baldwin – Director for a three-year term
Earth sciences board appointments:
David Smol – Chair for a three-year term
Mary-Anne Macleod – Deputy Chair for a two-year term
Paul Connell – Director for a three-year term
Paul White – Director for a two-year term
Peter Landon-Lane – Director for a three-year term
Professor Chris Bumby – Director for a two-year term
The Institute of Environmental Science and Research (ESR) will refocus as a health and forensic science services public research organisation. All three organisations will remain Crown Research Institutes until legislation enables their transition to Public Research Organisations in mid-2026.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
2 hours ago
- Scoop
OCR Cut Welcome For Some While Govt Leaves Many Behind
Poverty and homelessness continue to grow because of this Government's decisions, despite the Reserve Bank's move to lower the Official Cash Rate (OCR). 'The Reserve Bank's decision to lower interest rates today will be welcome news for some but won't help the thousands this Government has pushed into homelessness and poverty,' says Green Party co-leader and spokesperson for Finance Chlöe Swarbrick. 'Monetary policy is a blunt instrument. It is fiscal policy - that is, the Government's choices on tax and spend - which dictates who wins and who loses in our economy. 'While the OCR cut will provide some relief for those with a mortgage, the number of New Zealanders left out in the cold continues to grow under Luxon's decisions. Reports out today show families being forced to choose between unsafe boarding houses, or living on the street. 'Cuts to the OCR do not end poverty or homelessness, nor arrest growing inequality. The Government knows it can take action to address these problems, but is instead choosing to make them worse. 'While this Government tells people they're making the 'hard choices' to push more kids into poverty and increase emissions, the Greens will continue to fight for an Aotearoa where everyone thrives and nobody is left behind,' says Chlöe Swarbrick.
Scoop
3 hours ago
- Scoop
Cancer, Measles And Allergic Disease Research Funded In Latest HRC Grants Round
The Malaghan Institute has been awarded three Health Research Council grants, totalling $7.4M over five years, to improve cancer immunotherapies, protect vulnerable populations from measles outbreaks and investigate new therapeutic targets for eczema. Director Professor Kjesten Wiig says receiving three major grants from the Health Research Council at a time of heightened funding constraints is significant and recognises the calibre and relevance of the Malaghan Institute's science. 'These investments not only reflect confidence in the Malaghan's research across cancer, allergic and infectious diseases, but also the real-world impact of our work on the health of New Zealanders.' Faster CARs: Overcoming exhaustion to enhance cancer immunotherapies Building on the Malaghan Institute's ground-breaking CAR T-cell programme, the Perret team in the Weinkove Laboratory has recieved a $1.2 million project grant over three years to improve on this life-saving treatment. 'In Aotearoa's first CAR T-cell trial, our novel CAR T-cell therapy has shown promising safety and efficacy in people with relapsed lymphomas,' says Dr Rachel Perret. 'However, a known limitation of CAR T-cell therapies is that in some cases, cancers fail to respond, or relapse. This may be due to exhaustion of CAR T-cells during manufacture or inside the patient, due to a immunosuppressive environment around the tumour.' Cells, like people, can become exhausted if overworked or overstimulated, becoming less and less able to perform. However, unlike people, CAR T-cells can be tweaked to block the genes that signal this exhaustion, allowing them to continue fighting cancer for longer – which should also improve patient outcomes. 'This project will re-engineer CAR T-cells to silence genes linked to exhaustion and re-develop CAR T-cell manufacturing processes to enhance CAR T- cell fitness and shorten manufacturing times,' says Dr Perret. 'We expect the results to be applicable to many cancer types, and to be readily translated for the benefit of New Zealanders within our CAR T-cell clinical trial programme.' Providing equal protection for everyone against measles Herd immunity is how we as a population protect those who are immunocompromised or otherwise unable to get vaccinated (such as very young infants) against potentially life-threatening viruses like measles. When enough of the population are vaccinated (over 95% in the case of measles), this herd immunity effectively prevents viruses from spreading to our most vulnerable whānau. 'While the current measles, mumps and rubella (MMR) vaccine is highly effective at protecting vaccinated individuals against these viruses, current vaccination rates are not high enough to provide this essential herd immunity to protect those who cannot be vaccinated,' says paediatric immunologist Dr Kuang Hsiao from Waipapa Taumata Rau, University of Auckland, who is part of the research team. The MMR vaccine cannot be used in people with severely impaired immune systems and is not recommended in pregnant people. Also, MMR is less effective in infants, so is not routinely recommended before 12 months of age. In addition, Māori and Pacific communities are overrepresented among these vulnerable groups. For these populations, alternate protective options are required to prevent a measles outbreak. 'Evidence has shown that mRNA-based vaccines can be effective in these vulnerable individuals,' says the Malaghan's Professor Ian Hermans. 'With an international team involving clinicians, immunologists and Māori and Pacific researchers, we will develop an mRNA-based measles vaccine to give to vulnerable individuals in the event of an outbreak.' The research has been awarded an HRC Programme Grant, worth $5M over five years, and will bring together multiple organisations including the Malaghan, representing diverse areas of expertise and combining both fundamental research and public health. 'As part of this work, we will explore with Māori and Pacific communities' perceptions and beliefs about mRNA-based vaccines to support equitable access to the vaccine,' says Dr Hermans. Investigating novel treatment targets for atopic dermatitis Atopic dermatitis, or eczema, is a chronic skin allergic disease that affects a significant proportion of New Zealand's population. The disease can have a significant negative impact on a person's livelihood with symptoms varying from persistent itchiness, redness, dryness and inflammation. Current treatment options are largely immunosuppressants such as corticosteroids, which can cause side effects. While these treatments can help manage symptoms there are currently no effective therapies to prevent the disease from developing and relapsing. At the cellular level, one hallmark of atopic dermatitis is the chronic infiltration and persistence of immune cells called tissue resident memory T-cells. Normally, these cells are vital for protecting the skin from invading pathogens, but for individuals with atopic dermatitis these cells also contribute to the disease by promoting recurring inflammation even after the allergen has been cleared from the skin. The project, which has been awarded $1.2 million over three years, will be led by Dr Sotaro Ochiai, a Senior Research Fellow in the Ronchese Laboratory. The team will focus on better understanding these tissue resident memory T-cells identifying key genes and biological pathways that are essential for the establishment and maintenance of these cells in the skin. 'By understanding these mechanisms, we aim to identify new therapeutic targets to disrupt tissue resident memory T-cell survival or function and improve quality of life for those affected by this persistent and distressing condition,' says Dr Ochiai.
Techday NZ
5 hours ago
- Techday NZ
Seventy-two percent of New Zealanders say brands break promises
Nearly three-quarters of New Zealand consumers believe companies are not living up to the promises they make, according to a new study from Accenture Song. The Brand Experience Gap study, now in its second year, surveyed 1,527 New Zealanders and reviewed 65 brands across six sectors. The findings indicate that 72% of respondents feel brands are failing to deliver on their commitments, marking a slight increase from the previous year's figure of 71%. Financial services providers were rated as the best performing sector, with an experience gap of 63%, meaning that 63% of customers do not think their primary provider fulfils its promises. On the other end of the spectrum, media and entertainment firms - including content streaming services - had the largest experience gap at 79%. Consumer expectations Consumers identified specific areas where brands are falling short. In the financial services sector, 33% of respondents cited the need for more reasonable fees and interest rates as a key area for improvement. For media and entertainment, 81% wanted more control over how they manage and customise content, while 78% said content needs to be refreshed more regularly to avoid becoming repetitive or stale. Across all sectors, the three most significant shortfalls were consumers not feeling valued or recognised by brands (79%), perceptions that brands are not making a positive social contribution (78%), and a lack of up-to-date technology to make interactions more convenient (77%). Other industries assessed The study also measured the experience gap for other sectors in New Zealand. General insurance brands were found to have a gap of 71%, telecommunications providers 72%, utilities 68%, and travel and tourism 76%. With the experience gap persisting across most industries, Storm Day, NZ Lead at Accenture Song, commented on the growing expectations of New Zealand consumers: "Customers are demanding more from the brands they deal with, and rightly so. In an increasingly complex business environment, companies simply can't afford to promise what they can't deliver. Again in 2025, we're seeing a stubbornly high experience gap among brands in New Zealand. But this gap comes with an opportunity, as closing it is one of the best ways to build long-term customer trust." "The key is to treat customer experience as a purpose-led growth driver, not just a budget line item. Sectors like financial services are holding steady because they've invested in owning the customer experience, along with the systems and strategies to support it." "It's also important to remember that your brand doesn't exist in a vacuum. You might be closing gaps, but if your competitors are closing them faster, people notice that. Customers' experiences are framed by all the organisations they deal with, not just those in your sector. That's crucial, because customers don't always complain – they simply don't come back. They disappear silently, often to your competitors." "By harnessing smart technologies like generative AI to deliver genuine organisational purpose, we're on a mission to turn intent into action – and close the gap," said Day. Research methodology The Brand Experience Gap study measures the difference between what brands publicly promise and what their actual customers report experiencing. Respondents were asked about universal brand values - such as simplicity, ease of dealing with a company, and feeling valued - and sector-specific aspects like fraud protection in financial services. Results reflect the proportion of customers in each sector who feel there is a gap between a company's stated intentions and delivered outcomes. The report highlights a consistent challenge for New Zealand brands across industries: the need to improve how customers feel recognised, how technology is leveraged, and how brands contribute to society in order to rebuild trust and loyalty. Follow us on: Share on:
